

[ Tue, Jun 14th 2022
] - WOPRAI
[ Tue, Jun 14th 2022
] - WOPRAI
[ Tue, Jun 14th 2022
] - WOPRAI
[ Tue, Jun 14th 2022
] - WOPRAI
[ Tue, Jun 14th 2022
] - WOPRAI
[ Tue, Jun 14th 2022
] - WOPRAI
[ Tue, Jun 14th 2022
] - WOPRAI
[ Tue, Jun 14th 2022
] - WOPRAI
[ Tue, Jun 14th 2022
] - WOPRAI
[ Tue, Jun 14th 2022
] - WOPRAI
[ Tue, Jun 14th 2022
] - WOPRAI
[ Tue, Jun 14th 2022
] - WOPRAI
[ Tue, Jun 14th 2022
] - WOPRAI
[ Tue, Jun 14th 2022
] - WOPRAI

[ Mon, Jun 13th 2022
] - WOPRAI
[ Mon, Jun 13th 2022
] - WOPRAI
[ Mon, Jun 13th 2022
] - WOPRAI
[ Mon, Jun 13th 2022
] - WOPRAI
[ Mon, Jun 13th 2022
] - WOPRAI
[ Mon, Jun 13th 2022
] - WOPRAI
[ Mon, Jun 13th 2022
] - WOPRAI
[ Mon, Jun 13th 2022
] - WOPRAI
[ Mon, Jun 13th 2022
] - WOPRAI
[ Mon, Jun 13th 2022
] - WOPRAI
[ Mon, Jun 13th 2022
] - WOPRAI
[ Mon, Jun 13th 2022
] - WOPRAI
[ Mon, Jun 13th 2022
] - WOPRAI
[ Mon, Jun 13th 2022
] - WOPRAI
Jasper Hellweg Maintained (VRTX) at Strong Buy with Increased Target to $280 on, Jun 13th, 2022
Jasper Hellweg of Argus Research, Maintained "Vertex Pharmaceuticals Incorporated" (VRTX) at Strong Buy with Increased Target from $275 to $280 on, Jun 13th, 2022.
Jasper has made no other calls on VRTX in the last 4 months.
There are 12 other peers that have a rating on VRTX. Out of the 12 peers that are also analyzing VRTX, 6 agree with Jasper's Rating of Hold. Following are those relevant analyst calls for the last 4 months
- Brian Abrahams of "RBC Capital" Maintained at Hold and Held Target at $267 on, Sunday, June 12th, 2022
- David Risinger of "SVB Leerink" Initiated at Hold and Held Target at $265 on, Monday, May 23rd, 2022
- Do Kim of "Piper Sandler" Maintained at Hold with Decreased Target to $242 on, Friday, May 6th, 2022
- Brian Skorney of "Baird" Downgraded from Buy to Hold on, Friday, May 6th, 2022
- Paul Matteis of "Stifel" Maintained at Hold with Increased Target to $240 on, Thursday, May 5th, 2022
- Matthew Harrison of "Morgan Stanley" Upgraded from Sell to Hold and Held Target at $250 on, Tuesday, May 3rd, 2022
These are the ratings of the 6 analyists that currently disagree with Jasper
- Jason McCarthy of "Maxim Group" Upgraded from Hold to Strong Buy and Held Target at $325 on, Wednesday, June 1st, 2022
- Liisa Bayko of "Evercore ISI Group" Maintained at Buy and Held Target at $278 on, Tuesday, May 24th, 2022
- Mohit Bansal of "Wells Fargo" Maintained at Buy with Increased Target to $305 on, Friday, May 6th, 2022
- Gena Wang of "Barclays" Maintained at Buy and Held Target at $291 on, Thursday, May 5th, 2022
- Colin Bristow of "UBS" Maintained at Strong Buy with Decreased Target to $322 on, Wednesday, April 27th, 2022
- Hartaj Singh of "Oppenheimer" Maintained at Buy with Increased Target to $350 on, Monday, April 4th, 2022
Contributing Sources